NEW YORK (GenomeWeb News) – Sequenom said Friday evening that it has received notification from the US Patent and Trademark Office that a patent that was scheduled to issue next week has been withdrawn.

The USPTO said that it has withdrawn the issuance of US Patent No. 8,340,916 due to an anticipated patent interference proceeding between parties with pending patent applications or issued patents covering similar subject matter. Sequenom said that it had previously been notified by the USPTO that the patent would issue on Dec. 25.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.